Pseudolymphoma syndrome. A sensitivity to anticonvulsant drugs
- 1 March 1968
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 97 (3), 297-300
- https://doi.org/10.1001/archderm.97.3.297
Abstract
A clinical and histopathologic picture of a lymphoma suddenly occurring in a patient on anticonvulsant drug therapy may represent a peculiar response of the individual''s reticuloendothelial system to the drug. This case report exemplifies the phenomenon known as pseudolymphoma syndrome. Most anticonvulsant drugs can produce this picture with cross sensitizations, however, diphenylhydantoin (Dilantin) and mephenytoin (Mesantoin) are the commonest offenders.This publication has 5 references indexed in Scilit:
- The Development of Hodgkin’s Disease and Lymphoma during Anticonvulsant TherapyBlood, 1966
- Unique Syndromes Involving the Skin Induced by Drugs, Food Additives, and Environmental ContaminantsArchives of Dermatology, 1963
- Dilantin-induced serum sicknessAmerican Journal Of Medicine, 1963
- Drug Eruptions From Anticonvulsant DrugsArchives of Dermatology, 1963
- Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically and pathologically malignant lymphomasCancer, 1959